colleagues' concern that there may be bias toward patients with more progressive disease in the control group compared with the treated group appears unlikely. The 20% of patients in the control group who had discontinued immunomodulatory or immunosuppressive treatment in the first 3 to 6 weeks bec
β¦ LIBER β¦
Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes
β Scribed by H. S. Jun; L. Y. Khil; J. W. Yoon
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 203 KB
- Volume
- 59
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Glutamic acid decarboxylase antibodies i
β
Pasquale Striano; Giuseppe Perruolo; Luca Errichiello; Pietro Formisano; Frances
π
Article
π
2008
π
John Wiley and Sons
π
English
β 49 KB
Role of enteroviruses in the pathogenesi
β
M. Roivainen; K. Klingel
π
Article
π
2009
π
Springer
π
English
β 60 KB
IgG4-subclass of glutamic acid decarboxy
β
M. Hillman; C. TΓΆrn; H. Thorgeirsson; M. Landin-Olsson
π
Article
π
2004
π
Springer
π
English
β 151 KB
Enteroviruses in the pathogenesis of typ
β
Sisko Tauriainen; Sami Oikarinen; Maarit Oikarinen; Heikki HyΓΆty
π
Article
π
2010
π
Springer-Verlag
π
English
β 479 KB
Role of non-esterified fatty acids in th
β
Paolisso, G.; Howard, B.V.
π
Article
π
1998
π
John Wiley and Sons
π
English
β 92 KB
π 2 views
Over 30 years after the original description of Randle's cycle, the mechanisms by which elevated circulating non-esterified fatty acids might be causally related to glucose intolerance in Type 2 diabetes mellitus remain uncertain. This review examines the evidence that elevated plasma NEFA can inhib
Absence of glutamic acid decarboxylase a
π
Article
π
1999
π
Springer
π
English
β 37 KB